Interventions for Psychosis

Download:

Filtering by:

Age Cohort: 25 - 59 years

Health Promotion	Disease Prevention	Diagnostic	Curative	Rehabilitative	Palliative
Community Level
Community engagement [community sensitization on psychosis] Education directed at elimination of stigmatization of people living with mental health conditions Provision of IEC/BCC materials	Encourage compliance with medications		Promote functioning in activities of daily living and rehabilitation and inclusion in the community Early recognition of the need for referral
Primary Care
			Assessment for symptoms of anxiety Referral to the next level for specialized mental health investigation
Referral Facility: General
			Assessment of self-harm and suicide risk in people with mental, neurological, and substance use conditions History and physical examination for psychosis Basic laboratory tests Referral for self-harm and suicide risk in people with mental, neurological, and substance use conditions Promote functioning in activities of daily living and rehabilitation and inclusion in the community Provide interpersonal therapy (IPT) for psychotic disorders Psychoeducation and psychosocial support (including for patient’s carers) Oral anticholinergic medications for drug induced extrapyramidal side effects Intramuscular antipsychotics for psychosis Oral antipsychotics for psychosis
Referral Facility: Specialist
			Assessment of self-harm and suicide risk in people with mental, neurological, and substance use conditions History and physical examination for psychosis Basic laboratory tests Advanced laboratory tests Electroencephalography (EEG) Referral for self-harm and suicide risk in people with mental, neurological, and substance use conditions Promote functioning in activities of daily living and rehabilitation and inclusion in the community Provide interpersonal therapy (IPT) for psychotic disorders Psychoeducation and psychosocial support (including for patient’s carers) Provide cognitive behavioural therapy or interpersonal therapy for psychotic disorders Oral anticholinergic medications for drug induced extrapyramidal side effects Intramuscular antipsychotics for psychosis Oral antipsychotics for psychosis Oral antipsychotics for treatment-resistant psychosis Intravenous antipsychotics for treatment-resistant psychosis Oral benzodiazepines for catatonia Intramuscular benzodiazepines for catatonia Intravenous benzodiazepines for catatonia

Age Cohort: 60+ years

Health Promotion	Disease Prevention	Diagnostic	Curative	Rehabilitative	Palliative
Community Level
Community engagement [community sensitization on psychosis] Education directed at elimination of stigmatization of people living with mental health conditions Provision of IEC/BCC materials	Encourage compliance with medications		Promote functioning in activities of daily living and rehabilitation and inclusion in the community Early recognition of the need for referral
Primary Care
			Behavioural therapy Referral to the next level for specialized mental health investigation
Referral Facility: General
			Cognitive Therapy Individual psychotherapy Family therapy Group therapy/support groups “First-generation" antipsychotic “Second-generation" antipsychotic Psychosocial therapy
Referral Facility: Specialist
			Cognitive Therapy Individual psychotherapy Family therapy Group therapy/support groups “First-generation" antipsychotics “Second-generation" antipsychotics Psychosocial therapy Electroconvulsive therapy (ECT)